Release – Alliance Entertainment and JAKKS Pacific Team Up to Take Anime and VTuber Collectibles Further Across North America

Research News and Market Data on AENT

November 10, 2026 8:30 AM

Exclusive partnership pairs JAKKS’ anime product expertise with Alliance’s fan reach and distribution strength

PLANTATION, Fla. and SANTA MONICA, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (NASDAQ: AENT), an entertainment commerce and collectibles platform generating more than $1 billion in annual revenue and serving more than 35,000 retail and e-commerce storefronts, today announced an exclusive distribution partnership with JAKKS Pacific, Inc. (NASDAQ: JAKK), a leading global designer, manufacturer and marketer of toys and consumer products, for its anime and VTuber product lines. Under the agreement, Alliance will distribute JAKKS’ anime and VTuber products throughout North America, excluding mass retail.

The partnership brings together two companies that know this fandom. JAKKS brings the product: the design, development and manufacturing behind its anime division and the relationships that go with it. Alliance, one of the largest distributors of entertainment and collectibles in the industry, brings the reach: a presence at every major convention and fan event, deep ties to retailers and buyers, and a team of seasoned collectors who know how to connect with fans in an authentic way.

“We know anime, and we know what fans expect from the product,” said Ariana Berman, VP the Anime Division at JAKKS Pacific. “Alliance knows where those fans are, who the buyers are and how to show up for this community. Putting those two strengths together means more of our line in more of the right places, and we’re excited to build this next chapter with them.”

“What’s exciting about anime and VTuber collectibles is the connection fans have with the characters and creators they follow,” said Jeff Walker, Chief Executive Officer of Alliance Entertainment. “These are passionate communities that want products they can own, display and collect. We see a lot of opportunity to build on that enthusiasm together with JAKKS.”

“We see significant opportunity in the anime and VTuber space, and JAKKS is bringing compelling products and brands to the category,” said Tony Moyers, SVP Collectibles, Alliance Entertainment. “Alliance’s strength has always been connecting great products with the retailers, conventions, e-commerce channels, and collector communities that drive fandom. We’re excited to partner with JAKKS to expand distribution and help bring these offerings to fans across North America.”

The agreement covers distribution rights in North America, excluding mass retail.

For more information on JAKKS Pacific, visit www.jakks.com. For more information on Alliance Entertainment, visit www.aent.com.

About Alliance Entertainment

Alliance Entertainment (NASDAQ: AENT) is a premier distributor and fulfillment partner for the entertainment and pop culture collectibles industry. With more than 340,000 unique in-stock SKUs – including over 57,300 exclusive titles across compact discs, vinyl LPs, DVDs, Blu-rays, and video games – Alliance offers the largest selection of physical media in the market. Our vast catalog also includes licensed merchandise, toys, retro gaming products, and collectibles, serving over 35,000 retail locations and powering e-commerce fulfillment for leading retailers. Alliance also owns and operates proprietary collectibles brands, including Handmade by Robots™, a stylized vinyl figure line featuring licensed characters from leading entertainment franchises, and Alliance Authentic™, a premium platform for authentic, certified, and individually numbered entertainment collectibles. In addition, Alliance operates Endstate Authentic, a dedicated NFC-enabled authentication and digital product identity platform supporting authenticated collectibles, resale, and brand protection. Leveraging decades of operational expertise, exclusive sourcing relationships, and a capital-light, scalable infrastructure, Alliance connects fans and collectors to the products, franchises, and experiences they value across formats and generations. For more information visit www.aent.com.

About JAKKS Pacific, Inc.

JAKKS Pacific, Inc. is a leading designer, manufacturer and marketer of toys and consumer products sold throughout the world, with its headquarters in Santa Monica, California. JAKKS Pacific’s popular proprietary brands include Disguise®, Fly Wheels®, Charming™, Kidtopia™, Moose Mountain®, Maui®, ReDo® Skateboard Co., Sky Ball®, and Xtreme Power Dozer® as well as a wide range of entertainment-inspired products featuring premier licensed properties. Through their products and charitable donations, JAKKS is helping to make a positive impact on the lives of children. Visit us at www.jakks.com and follow us on Instagram (@jakkspacific.toys), X (@jakkstoys), YouTube (@JAKKSPacific), Facebook (@jakkspacific.toys) and LinkedIn (JAKKS Pacific).

Forward Looking Statements

Certain statements included in this Press Release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the anticipated timing and volume of NFC deployment, AGS’s growth and capacity expansion, commercial adoption of the combined offering, potential revenue opportunities and investment value, estimates and forecasts of other financial and performance metrics, and projections of market opportunity. These statements are based on various assumptions, whether or not identified in this Press Release, and on the current expectations of Alliance’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Alliance. These forward-looking statements are subject to a number of risks and uncertainties, including risks relating to the anticipated growth rates and market opportunities; changes in applicable laws or regulations; the ability of Alliance to execute its business model, including market acceptance of its systems and related services; Alliance’s reliance on a concentration of suppliers for its products and services; increases in Alliance’s costs, disruption of supply, or shortage of products and materials; Alliance’s dependence on a concentration of customers, and failure to add new customers or expand sales to Alliance’s existing customers; increased Alliance inventory and risk of obsolescence; Alliance’s significant amount of indebtedness; our ability to refinance our existing indebtedness; risks that a breach of the revolving credit facility could result in the lender declaring a default and that the full outstanding amount under the revolving credit facility could be immediately due in full, which would have severe adverse consequences for the Company; known or future litigation and regulatory enforcement risks, including the diversion of time and attention and the additional costs and demands on Alliance’s resources; Alliance’s business being adversely affected by increased inflation, uncertainty regarding tariffs, higher interest rates and other adverse economic, business, and/or competitive factors; geopolitical risk and changes in applicable laws or regulations; as well as our financial condition and results of operations; substantial regulations, which are evolving, and unfavorable changes or failure by Alliance to comply with these regulations; product liability claims, which could harm Alliance’s financial condition and liquidity if Alliance is not able to successfully defend or insure against such claims; availability of additional capital to support business growth; and the inability of Alliance to develop and maintain effective internal controls.

Media Contacts:

JAKKS Pacific
Jessica Kavanaugh
[email protected]

Alliance Entertainment
Evan McWhirter
[email protected]

Alliance Entertainment Investor Contact:

Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
[email protected]

Release – An Investigational Drug to Tackle Measles Outbreaks

An Investigational Drug to Tackle Measles Outbreaks

Research News and Market Data on NNVC

Tuesday, 10 November 2026 08:45 AM

SHELTON, CT / ACCESS Newswire / November 10, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announces that it is advancing its Measles drug development program towards clinical trials.

There have been three deaths in children due to Measles in the USA in the last ten days, one each in the states of New York, Pennsylvania, and Wisconsin i.

This condition should be unacceptable in the USA because there is already a drug against Measles that has shown effectiveness in a humanized animal model of Measles, that has gone through extensive studies including Phase I human safety study, and that is already in two Phase II clinical trials for other viral infections.

This investigational drug is NV-387, a novel, revolutionary broad-spectrum, antiviral drug developed by the Company. This drug has completed a juvenile animal model study as well. NV-387 is not yet FDA-approved or commercially available for treating Measles or any other viral disease. However, we believe the drug NV-387 now has sufficient data available to enable use under the US FDA physician-initiated investigational new drug application mechanism that is designed for use of experimental drugs for specific severe cases of disease, such as Measles. The Company continues to develop this drug in the regulatory pathways.

There were 5,164 confirmed Measles cases within the USA (excluding international visitors) as of November 5, 2026, reported in 47 jurisdictions, with 4% of these being breakthrough cases in vaccinated individuals, and remaining 96% in unvaccinated individuals. 562 (11%) of the cases were hospitalized, and 4 confirmed Measles-caused deaths were recorded. A few additional deaths in Measles cases that are under CDC review have also occurred. Majority of hospitalizations occurred in children under 5 years of age. Only 4 states, namely Arkansas, Hawaii, Mississippi, and Nevada have not reported a Measles case in 2026, according to the CDC ii. These data indicate that Measles in the USA is continuing to expand in 2026.

At this point, loss of the Measles elimination status achieved by the USA in 2000 as the very first country to achieve this status would be merely symbolic, emphasizing that Measles is a globally endemic virus with a very high potential for creating a contagion.

Vaccines, even though effective, are inadequate as the only response to such a disease as Measles, and drugs to treat Measles infections are sorely needed.

Of note, the D8 genotype of the Measles virus dominates in 2026 US cases iii whereas the Measles vaccine is based on the A genotype.

NV-387, the Company’s revolutionary clinical stage broad-spectrum antiviral drug is currently in a Phase II clinical trials as an oral treatment for the Ebola Bundibugyo virus epidemic in the Democratic Republic of Congo (DRC).

The same drug, NV-387, formulated as the same oral gummies formulation is also in a Phase II clinical trial for the treatment of Mpox (Monkeypox) in DRC in a different province.

This very same drug has demonstrated remarkable antiviral activity against the Measles virus in a humanized hCD150+, IfnAR-/- mouse model of Measles virus infection and disease.

The Company has also completed a repeat-dose juvenile mouse model toxicity study in which 4-day old mouse pups were dosed with repeated doses of NV-387 oral gummies formulation to evaluate the safety and tolerability of the drug and drug product in the context of the use of the drug in children.

Under the conditions of this Juvenile Mouse Model study, the No Observed Adverse Effect Level (NOAEL) was determined to be 1,230 mg/kg per dose administered three times daily, or 3,690 mg/kg/day, or a total cumulative drug exposure of 44,280 mg/kg over the 12 day dosing period. This was actually the highest dose level tested. Therefore, a Maximum Tolerable Dose (MTD) could not be estimated iv.

Further, there was no mortality, systemic toxicity, treatment-related clinical observations, adverse effects on body weight gain, alterations in cardiovascular parameters, changes in clinical pathology, or treatment-related gross or microscopic pathological findings observed in either sex.

According to established guidelines for juvenile animal model data extrapolation, a drug evaluated for safety toxicology in 4 day mouse pups supports clinical pediatric study in infants as young as 1 month v, under an appropriate regulatory study.

Cases of Measles have been rising globally for different reasons. The measles outbreak in Bangladesh has continued to proliferate, claiming 24,073 lab-confirmed cases with 105 fatalities in lab-confirmed cases from 15 March to 10 November, 2026. During this period, a total of 207,428 patients with suspected measles were hospitalized and 1,263 persons, mostly children, have died of suspected measles, while 1,318 new suspected measles cases with at least 6 more child deaths were reported in just the last 24 hours in Bangladesh vi. The measles outbreak in Bangladesh has continued despite aggressive vaccination campaign that was undertaken since April-May 2026.

There is currently no approved drug for measles. Vaccine does not help a patient already infected with the measles virus. Vaccinating already measles-exposed persons to avoid disease spread is attempted yet measles has continued to spread in the USA.

Thus an effective treatment for Measles is an unmet medical need. NV-387 is the only drug candidate to our knowledge that has demonstrated strong in vivo activity against lethal infection with the Measles virus in a humanized animal model study, supporting its clinical regulatory development for treatment of Measles.

NanoViricides is currently developing a Phase II clinical trial protocol for evaluating NV-387 as a treatment for measles. A draft is being circulated. The Company intends to bring this protocol under the purview of the US FDA in an IND process. Therefore, this work is expected to take some time.

NV-387 has been granted a “Rare Pediatric Disease Drug” (RPDD) Designation by the US FDA Office of Orphan Products Development (OOPD).

This RPDD designation enables that a Priority Review Voucher (PRV) can be issued to the Company upon a successful Marketing Application (i.e. New Drug Application) for the use of NV-387 as a treatment for Measles, provided all of the required conditions are met. The Company can use the PRV, if granted, to reduce review times on another of its drug applications.

A PRV can be sold to another Pharma Company for accelerating their drug program as well, which provides a high value to the purchaser. PRVs have been sold for as much as $200 Million vii.

“The Rare Pediatric Disease Drug Designation and associated Priority Review Voucher that can be issued make a strong business case for development of NV-387 as a drug for the treatment of Measles,” said Anil R. Diwan, PhD., adding, “NV-387, as an effective drug would be an important tool to fight Measles resurgence in the USA and worldwide, when approved.”

FDA has granted both ODD and RPDD for NV-387 as a Treatment of Measles.

In addition to the PRV eligibility provided by the RPDD for NV-387 as a treatment of Measles, the Orphan Drug Designation qualifies NanoViricides for incentives including:

Tax credits for qualified clinical trials;

  • Exemption from certain user fees;
  • Potential seven years of market exclusivity after approval;

according to the US FDAviii.

Measles continues to be a rare disease in the USA, with annual incidence rates well below 200,000 cases. Measles primarily affects children. These facts have qualified NV-387 for Measles Treatment for an Orphan Drug Designation, and also for a Rare Pediatric Disease Drug Designation. In a rare disease scenario, commercial revenue from the drug may be slow and small. The PRV is designed to incentivize drug development for rare pediatric diseases by providing additional business value.

Measles cases are rising across the Western world including several European countries and the UK, as well as the USA and Canada. Additionally Mexico and several other Central and South American countries have also been suffering from rising Measles outbreaks.

Measles is endemic globally; many countries that had achieved an elimination status for Measles have by now lost this status, due to severe outbreaks over the last three years ix.

Measles is a highly contagious disease, and spreads via virus particles in bodily fluids upon close contact. A population vaccination rate of at least 95% is required to provide “herd immunity” and block community spread. Such a high rate is difficult to maintain for several reasons. Firstly, vaccine hesitancy is rising globally. Secondly, persons with co-morbidities such as immune-compromise status, diabetes, obesity, etc. do not respond fully to any vaccination. Even if vaccinated, such a person can still get Measles, suffering from possibly a mild disease, but will still be contagious and spread Measles. Additionally, the Measles virus continues to change, with the B and D genotypes in circulation currently, while the vaccines in use are still the ones developed for the A genotype in the 1960’s.

Further, very high rates of infections in vaccinated subjects (called “breakthrough cases”), from 14% to 57%, have occurred in some outbreaksx suggesting that resistant virus strains may have been involved.

Therefore, an effective treatment for Measles is an unmet medical need, that is expected to become even more important in the near future than it is today. Only an effective treatment can help the patient and can avoid the potential severe disease scenarios such as encephalitis, neurological disabilities, and potential fatalities as well as immune amnesia that can result from severe disease.

Quicker recovery of a patient means less chances for spread and thus better ability to control an outbreak. This would require an effective treatment.

NV-387 is an extremely broad-spectrum antiviral drug that has demonstrated strong effectiveness in relevant animal models of multiple human viral infections. These include RSV, COVID, Influenza, Mpox, Smallpox, and Measles.

ABOUT NANOVIRICIDES

NanoViricides, Inc. (the “Company”) (www.nanoviricides.com) is a publicly traded (NYSE-American, stock symbol NNVC) clinical stage company that is creating special purpose nanomaterials for antiviral therapy. The Company’s novel nanoviricide™ class of drug candidates and the nanoviricide™ technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The Company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments.

The Company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The Company’s business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005.

Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. Our other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. The Company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. The Company is currently focused on advancing NV-387 into Phase II human clinical trials.

The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides’ platform technology and programs are based on the TheraCour® nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus, Ebola/Marburg viruses, and certain Coronaviruses. The Company intends to obtain a license for RSV, Poxviruses, and/or Enteroviruses if the initial research is successful. As is customary, the Company must state the risk factor that the path to typical drug development of any pharmaceutical product is extremely lengthy and requires substantial capital. As with any drug development efforts by any company, there can be no assurance at this time that any of the Company’s pharmaceutical candidates would show sufficient effectiveness and safety for human clinical development. Further, there can be no assurance at this time that successful results against coronavirus in our lab will lead to successful clinical trials or a successful pharmaceutical product.

This press release contains forward-looking statements that reflect the Company’s current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.

The phrases “safety”, “effectiveness” and equivalent phrases as used in this press release refer to research findings including clinical trials as the customary research usage and do not indicate evaluation of safety or effectiveness by the US FDA.

FDA refers to US Food and Drug Administration. IND application refers to “Investigational New Drug” application. cGMP refers to current Good Manufacturing Practices. CMC refers to “Chemistry, Manufacture, and Controls”. CHMP refers to the Committee for Medicinal Products for Human Use, which is the European Medicines Agency’s (EMA) committee responsible for human medicines. API stands for “Active Pharmaceutical Ingredient”. WHO is the World Health Organization. R&D refers to Research and Development.

Contact:
Attn: Media Contact
NanoViricides, Inc.
1 Controls Drive, Shelton, CT 06484.
Tel: +1 (203) 937-6137.
[email protected]

Public Relations Contact:
[email protected]

Source: NanoViricides, Inc. Primary Account.

i https://www.contagionlive.com/view/measles-update-november-6-2026 .

ii https://www.cdc.gov/measles/data-research/index.html

iii GenomicEpi Measles Surveillance Report · 2026, created November 7, 2026.

iv NOAEL is the highest amount of drug exposure at which there are no significant increases in adverse effects compared to a control group. MTD is the highest amount of drug exposure that does not cause unacceptable side effects or overt toxicity.

v Barrow, PC, and Schmitt, G. “Juvenile Nonclinical Safety Studies in Support of Pediatric Drug Development,” Methods Mol Biol. 2017:1641:25-67. doi: 10.1007/978-1-4939-7172-5_2.

vi https://www.tbsnews.net/bangladesh/health/measles-death-toll-reaches-1263-6-more-children-die-1591441

vii https://prvwatch.com/

viii https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products

ix https://www.cfr.org/articles/many-countries-eliminated-measles-why-is-it-coming-back-in-the-u-s-and-globally

x Fappani,et al. Breakthrough Infections: A Challenge towards Measles Elimination?. Microorganisms 2022, 10, 1567. https://doi.org/10.3390/microorganisms10081567

SOURCE: NanoViricides

Release – VivoPower Confirms Strategic Update and Results Conference Call Moved to November 16, 2026

Research News and Market Data on VIVO

VivoPower PLC (Nasdaq: VIVO) (“VivoPower” or the “Company”), a leading B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced that its previously scheduled results conference call and webcast has been rescheduled from November 10, 2026, to Monday, November 16, 2026, at 8:00 a.m. Eastern Time.

The call, now titled “Strategic Update and Results Presentation,” will provide investors and analysts with a review of the Company’s financial results and strategic developments.

Webcast access and telephone dial-in details are available on VivoPower’s investor relations website at https://www.vivopower.com/investors.

Forward-Looking Statements

This communication includes certain statements that may constitute “forward-looking statements” for purposes of the U.S. federal securities laws. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this communication include, for example, statements about the expected date, time and format of the Company’s FY2026 results conference call and webcast and the matters expected to be covered on the call.

These statements are based on VivoPower’s management’s current expectations or beliefs and are subject to risk, uncertainty, and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to risks, uncertainties and contingencies including: (i) changes to the date, time or format of the conference call and webcast, including as a result of scheduling, technical or logistical factors; (ii) changes in economic, business, competitive and/or regulatory factors, geopolitical events and general market volatility; and (iii) other factors set forth in VivoPower’s filings with the United States Securities and Exchange Commission. The information set forth herein should be read in light of such risks. VivoPower is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise.

Contact

Shareholder Enquiries
[email protected]

‍

November 10, 2026

Release – Kratos and Seagate Space Partner to Advance Mobile Offshore Launch Capabilities for National Security Missions

Primary Logo

Research News and Market Data on KTOS

November 10, 2026

PDF Version

Long-term Gateway agreement supports Kratos’ first offshore mission in 2027 and multiple planned launches in subsequent years

Gateway™ offshore launch platform
Gateway™ offshore launch platform

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6bce8d6c-8a04-4d2e-bad7-c7d636371732

SAN DIEGO, Nov. 10, 2026 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a technology company in defense, national security, and global markets, today announced a long-term agreement with Seagate Space for use of the company’s initial Gateway™ offshore launch platform. The agreement supports Kratos’ planned first mission from the platform in 2027, with multiple additional launches anticipated in subsequent years.

The partnership aligns Kratos’ mission of being first to market and proven record of delivering real, mission-relevant products and systems, including hypersonic test and other vehicles, rocket systems, propulsion technologies, target vehicles, and launch services, with Seagate Space’s modular, mobile offshore platform infrastructure. The Gateway series vessels are designed to provide flexible sea-based platforms to complement traditional land-based launch sites and test ranges.

The announcement coincides with Seagate Space’s execution of its first Gateway platform construction contract, advancing into physical construction and toward future operational readiness.

“Kratos’ agreement with Seagate Space creates an important new pathway for supporting our customers’ evolving launch and test requirements,” said Dave Carter, President of Kratos Defense & Rocket Support Services. “We are focused on delivering affordable, responsive, and mission-critical solutions. Gateway has the potential to provide our customers with additional launch flexibility, expanded operating locations, and responsive access to mission-relevant test environments.”

Seagate Space’s Gateway platform is being developed as a modular and mobile offshore system to support government and commercial launch, testing, and recovery missions. Its maritime mobility can provide mission planners with added flexibility in launch geometry, range access, and scheduling while reducing dependence on fixed terrestrial infrastructure.

Kratos plans to use the Gateway platform initially in support of defense-related launch and target missions. The companies expect their collaboration to establish a foundation for expanded offshore mission operations as demand grows for hypersonic testing, ballistic-missile targets, responsive launch capabilities, and other national security relevant missions.

“From the beginning, our vision has been to make access to space as open as the ocean itself,” said Sean Fortener, President, Chief Operating Officer and Co-Founder of Seagate Space. “Partnering with Kratos and moving our first Gateway platform into construction represents a major step towards making that vision a reality. Kratos brings real mission requirements and decades of defense experience, and Seagate Space is bringing the maritime infrastructure to support them. With our first build contract signed, we are putting steel behind the vision and moving closer to delivering a capability the industry needs.”

Kratos has internally invested in rapidly developing and fielding affordable systems for demanding national security missions. Kratos’ approach is based on the belief that affordability is a technology: designing proven, leading-edge products and systems from the outset for rapid production, operational deployment, and scalable manufacturing.

“Kratos is committed to being first to market with affordable, relevant, mission-focused technology and systems that address the urgent requirements of the United States and its allies,” said Eric DeMarco, Kratos President and CEO. “This partnership with Seagate Space supports our mission and strategy, by creating an additional option for our customers to conduct critical launch and test missions. Sea-based launch infrastructure can provide flexibility, responsiveness, and operational choice—capabilities increasingly important to national security missions.”

The companies will continue to advance Gateway through construction, integration, and operational-readiness activities in preparation for Kratos’ first planned mission in 2027.

About Kratos Defense & Security Solutions, Inc.
Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) is a technology, products, system and software company addressing the defense, national security, and commercial markets. Kratos makes true internally funded research, development, capital and other investments, to rapidly develop, produce and field solutions that address our customers’ mission critical needs and requirements. At Kratos, affordability is a technology, and we seek to utilize proven, leading edge approaches and technology, not unproven bleeding edge approaches or technology, with Kratos’ approach designed to reduce cost, schedule and risk, enabling us to be first to market with cost effective solutions. We believe that Kratos is known as an innovative disruptive change agent in the industry, a company that is an expert in designing products and systems up front for successful rapid, large quantity, low cost future manufacturing which is a value add competitive differentiator for our large traditional prime system integrator partners and also to our government and commercial customers. Kratos intends to pursue program and contract opportunities as the prime or lead contractor when we believe that our probability of win (PWin) is high and any investment required by Kratos is within our capital resource comfort level. We intend to partner and team with a large, traditional system integrator when our assessment of PWin is greater or required investment is beyond Kratos’ comfort level. Kratos’ primary business areas include virtualized ground systems for satellites and space vehicles including software for command & control (C2) and telemetry, tracking and control (TT&C), jet powered unmanned aerial drone systems, hypersonic vehicles and rocket systems, propulsion systems for drones, missiles, loitering munitions, supersonic systems, space craft and launch systems, C5ISR and microwave electronic products for missile, radar, missile defense, space, satellite, counter UAS, directed energy, communication and other systems, and virtual & augmented reality training systems for the warfighter. For more information, visit www.KratosDefense.com and follow Kratos on LinkedIn and X.

About Seagate Space
Seagate Space is space’s maritime partner: reinventing offshore launch, optimizing recovery, and innovating for emerging logistics needs. The company’s cutting-edge designs enable rapid, cost-effective development of offshore launch assets that can operate without the constraints of traditional land-based ranges. Seagate Space is a spARK Labs by ARK Invest member company headquarter in the St. Petersburg, Florida. Learn more at seagatespace.com and follow us on LinkedIn.

Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 28, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.

Press Contact:
Claire Cantrell
[email protected]

Investor Information:
877-934-4687
[email protected]

Release – Snail, Inc. Sets Third Quarter 2026 Conference Call for Thursday, November 12, 2026 at 4:30 p.m. ET

Snail, Inc logo

Research News and Market Data on SNAL

November 10, 2026 at 8:30 AM EST

PDF Version

CULVER CITY, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, will hold a conference call and webcast on Thursday, November 12, 2026 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the third quarter ended September 30, 2026.

Snail Games management will host the conference call and webcast, followed by a question-and-answer period. Participants may listen to the live webcast and replay via the link here or on the Company’s investor relations website at https://investor.snail.com/.

About Snail, Inc.
Snail, Inc. (Nasdaq: SNAL) is a leading, global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PCs, and mobile devices. For more information, please visit: https://snail.com/.

Investor Contact:
John Yi and Steven Shinmachi
Gateway Group, Inc.
949-574-3860
[email protected]

Release – Graham Corporation Completes CMMC Assessments at Two Business Units, Enhancing Defense Market Readiness and Cybersecurity for its Business Systems

Graham Corporation

Research News and Market Data on GHM

November 10, 2026 8:00am ESTDownload as PDF

BATAVIA, N.Y.–(BUSINESS WIRE)– Graham Corporation (NYSE: GHM) (“GHM” or the “Company”), a global leader in the design and manufacture of mission critical fluid, power, heat transfer, vacuum and advanced mixing technologies for the Defense, Space and Energy & Process industries, today announced that both its Graham Manufacturing and Barber-Nichols business units have successfully completed Cybersecurity Maturity Model Certification (CMMC) assessments, reinforcing the company’s commitment to cybersecurity excellence and the protection of sensitive customer and defense-related information.

The successful assessments reinforce Graham’s commitment to safeguarding sensitive information while enhancing the Company’s ability to compete for and execute work supporting national security, defense, aerospace and other mission-critical applications.

The assessments validate that both business units have implemented cybersecurity practices aligned with Department of Defense requirements for protecting sensitive government information. As cybersecurity requirements become an increasingly important factor in contract awards and supplier qualification, maintaining compliance helps position Graham to pursue strategic opportunities across the defense and aerospace sectors.

“Cybersecurity is a strategic business imperative and a critical part of our commitment to operational excellence and national security,” said Keith Oufnac, Chief Information Officer of Graham Corporation. “Successfully completing these assessments at Graham Manufacturing and Barber-Nichols reflects the dedication, discipline and collaboration of our teams and demonstrates our ability to implement and maintain cybersecurity controls across diverse operations. This achievement further strengthens our position as a trusted supplier for mission-critical programs, supporting the evolving needs of our defense, aerospace, energy and government customers.”

The assessments are part of Graham Corporation’s broader strategy to strengthen operational excellence, reduce enterprise risk and support sustainable growth across its product portfolio. The Company remains committed to continuous improvement in cybersecurity, compliance and technology capabilities that enable long-term value creation for customers and shareholders.

About Graham Corporation

Graham is a global leader in the design and manufacture of mission critical fluid, power, heat transfer, vacuum and advanced mixing technologies for the Defense, Space, Energy & Process industries. Graham Corporation and its family of global brands are built upon world-renowned engineering expertise, proprietary technologies, as well as its responsive and flexible service and the unsurpassed quality customers have come to expect from the Company’s products and systems. Graham Corporation routinely posts news and other important information on its website, grahamcorp.com, where additional information on Graham Corporation and its businesses can be found.

Safe Harbor Regarding Forward Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as “continue,” “expects,” “future,” “opportunities,” “strategy,” and other similar words. All statements addressing operating performance, events, or developments that Graham Corporation expects or anticipates will occur in the future, including but not limited to, profitability of future projects and the business, its ability to deliver to plan, its ability to continue to strengthen relationships with customers in the Defense industry, its ability to secure future projects and applications, expected expansion and growth opportunities, capital expenditures and SG&A expenses, and customer preferences, are forward-looking statements. Because they are forward-looking, they should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Graham Corporation’s most recent Annual Report filed with the Securities and Exchange Commission (the “SEC”), included under the heading entitled “Risk Factors”, and in other reports filed with the SEC.

Should one or more of these risks or uncertainties materialize or should any of Graham Corporation’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Graham Corporation’s forward-looking statements. Except as required by law, Graham Corporation disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261110579304/en/

For more information, contact:

Christopher J. Thome
Vice President – Finance and CFO
Phone: (585) 343-2216

Tom Cook
Investor Relations
(203) 682-8250
[email protected]

Source: Graham Corporation

Release – Ocugen and Celairis Therapeutics Enter into Exclusive License Agreement for OCU400 in Australia, New Zealand, and ASEAN

Research Nes and Market Data on OCGN

November 10, 2026

PDF Version

  • Celairis receives exclusive rights to commercialize OCU400, Ocugen’s investigational modifier gene therapy for retinitis pigmentosa (RP), in Australia, New Zealand, and member states of the Association of Southeast Asian Nations (ASEAN) markets
  • Expands access to a potential one-time treatment gene therapy for RP across a region with an estimated 725 million people, following potential OCU400 approval in the U.S.
  • Ocugen receives an upfront license fee, potential development and milestone payments totaling up to $7.1 million, including $6.1 million associated with the upfront payment and OCU400 top-line results (expected in the first quarter of 2027), a high single-digit percentage royalty on net sales, and 50% of gross profits from OCU400 net sales across the region
  • Celairis will be responsible for regional regulatory submissions, market access, and commercialization of OCU400 across the region

MALVERN, Pa. and SYDNEY, Nov. 10, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, and Celairis Therapeutics Holdings Pty Ltd. (“Celairis”), a Sydney-based in-licensing, development, and commercialization biopharmaceutical company focused on Australia, New Zealand, Taiwan, and ASEAN, today announced the execution of an exclusive license agreement (the “License Agreement”) granting Celairis an exclusive license to commercialize OCU400, Ocugen’s investigational modifier gene therapy for the treatment of RP, in Australia, New Zealand, and ASEAN markets (the “Territory”).

Under the terms of the License Agreement, Ocugen will receive an upfront license fee, as well as potential development and milestone payments totaling up to $7.1 million, including $6.1 million associated with the upfront payment and OCU400 top-line results (expected in the first quarter of 2027), a high single-digit percentage royalty on net sales, and 50% of gross profits from OCU400 net sales in the Territory. The parties expect to enter into a supply agreement, pursuant to which Ocugen will manufacture and supply OCU400. Celairis will be responsible for regional regulatory submissions, market access, and commercialization of OCU400 across the Territory.

“Australia, New Zealand, and ASEAN are large, diverse and complex markets, and establishing a partnership with a regional company like Celairis and its strong local network is critical to our goal of global patient access,” said Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-Founder of Ocugen. “This agreement marks our third strategic regional partnership for OCU400, underscoring the growing momentum behind our global access strategy and bringing our potential one-time treatment gene therapy closer to patients around the world.”

OCU400 is an investigational therapy for RP, a group of inherited retinal diseases that cause progressive vision loss, and in many cases, blindness. OCU400 has not been approved or registered and is not available for supply in any markets of the Territory. Ocugen is conducting the Phase 3 liMeliGhT clinical trial of OCU400, with topline data expected in the first quarter of 2027, followed by planned global regulatory submissions, including a Biologics License Application in the U.S. and a Marketing Authorization Application in Europe. Regulatory submissions in the Territory are expected to follow.

“Ocugen is the kind of partner Celairis was built for: a late-stage program, a clear strategy for reaching patients globally, and a conviction we share that geography should not decide access to new medicines,” said Matt Zeller, Chief Executive Officer, Co-Founder, and Managing Director of Celairis. “Celairis brings the development, regulatory, and market access capability to do that across our region, and we look forward to building the relationship with Ocugen.”

About Ocugen, Inc.

Ocugen, Inc. is a pioneering biotechnology company developing gene therapies for blindness diseases. The Company’s breakthrough modifier gene therapy platform has the potential to address significant unmet medical needs across large patient populations through a gene-agnostic approach. Unlike traditional gene therapies and gene-editing technologies that target a single gene mutation, Ocugen’s modifier gene therapies are designed to address the underlying disease biology by restoring balance across multiple gene networks. The Company is currently advancing programs for inherited retinal diseases and other causes of blindness that affect millions worldwide, including retinitis pigmentosa, Stargardt disease, and geographic atrophy, an advanced form of dry age-related macular degeneration. Discover more at www.ocugen.com and follow the Company on LinkedIn and X.

About Celairis Therapeutics

Celairis Therapeutics is an in-licensing, development, and commercialization biopharmaceutical company unlocking broad and equitable access to advanced therapies for patients across 14 markets in Australia, New Zealand, Taiwan, and ASEAN. Celairis secures regional rights to medicines in oncology and hematology, specialty conditions, and rare diseases, then runs clinical development, regulatory approval, market access, supply chain, and commercial launch on one end-to-end platform. Founded in 2026, Celairis is headquartered in Sydney, Australia. For more information, visit www.celairis.com and follow Celairis on LinkedIn.

Cautionary Note on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the anticipated benefits to Ocugen of the license agreement and planned supply agreement with Celairis, as well as statements regarding strategy, the potential amounts of milestone payments and profit share payments that may be received under the license agreement, including Ocugen’s obligations under its prior license and commercialization agreements, the timing of regulatory submissions and the potential availability of OCU400 in the Territory, business plans and objectives for Ocugen’s clinical programs, plans and timelines for the preclinical and clinical development of Ocugen’s product candidates, including the therapeutic potential, clinical benefits and safety thereof, expectations regarding timing, success and data announcements of current ongoing preclinical and clinical trials, including the timing of data readouts and marketing applications, the ability to initiate new clinical programs, statements regarding qualitative assessments of available data, potential benefits, expectations for ongoing clinical trials, anticipated regulatory filings and anticipated development timelines, statements regarding potential market size and commercial possibilities of Ocugen’s product candidates, which are subject to risks and uncertainties. Ocugen may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from Ocugen’s current expectations, including, but not limited to, the risks that the license agreement and planned supply agreement with Celairis will not lead to the current anticipated benefits to Ocugen; that the supply agreement with Celairis will not be entered into; that OCU400 may not receive regulatory approval in any jurisdiction, including in the Territory; that preliminary, interim and top-line clinical trial results may not be indicative of, and may differ from, final clinical data; that unfavorable new clinical trial data may emerge in ongoing clinical trials or through further analyses of existing clinical trial data; that earlier non-clinical and clinical data and testing may not be predictive of the results or success of later clinical trials; and that clinical trial data are subject to differing interpretations and assessments, including by regulatory authorities. These and other risks and uncertainties are more fully described in Ocugen’s filings with the Securities and Exchange Commission (SEC), including the risk factors described in the section entitled “Risk Factors” in the quarterly and annual reports that Ocugen files with the SEC. Any forward-looking statements that Ocugen makes in this press release speak only as of the date of this press release. Except as required by law, Ocugen assumes no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.

Contacts

Ocugen
Investors: Candice Masse, astr partners, [email protected]
Media: Chris Clark, Ocugen, [email protected]

Celairis Therapeutics
Media: [email protected]

Release – Summit Midstream Corporation Reports Third Quarter 2026 Financial and Operating Results

Summit Midstream Partners Logo. (PRNewsFoto/Summit Midstream Partners)

Research News and Market Data on SMC

PDF Version

HOUSTON, Nov. 9, 2026 /PRNewswire/ — Summit Midstream Corporation (NYSE: SMC) (“Summit”, “SMC” or the  “Company”) announced today its financial and operating results for the three months ended September 30, 2026.

Highlights

  • Third quarter 2026 net income of $15.9 million, Adjusted EBITDA of $70.7 million, an increase of 16% relative to the second quarter of 2026, cash flow available for distributions (“Distributable Cash Flow” or “DCF”) of $32.6 million and free cash flow (“FCF”) of $5.2 million
  • Raised 2026 Adjusted EBITDA guidance range to $250 million to $260 million, from $235 million to $255 million, amid strong producer activity and growing Rockies volumes, and expect a year-end 2026 total net leverage ratio of approximately 3.6x1
  • Reached final investment decision on the Double E Mainline Compression Expansion, further positioning Summit to serve growing Permian Basin customer demand
  • Double E throughput increased 17% to a record 1,002 MMcf/d relative to the second quarter of 2026, and the pipeline remains on track to fully subscribe the remaining forward-haul capacity by year-end
  • Rockies Segment Adjusted EBITDA increased 32% to $40.0 million relative to the second quarter of 2026, driven by a 40% increase in liquids volume throughput
  • Mid-Con Segment Adjusted EBITDA increased 7% to $22.8 million relative to the second quarter of 2026, driven by a 7% increase in natural gas volume throughput to 561 MMcf/d
1 Based on the midpoint of the updated Adjusted EBITDA guidance range.

Management Commentary

“The third quarter was one of the strongest in Summit’s history, driven by an active customer base and a supportive commodity price environment. Fifty-one new wells came online across the Williston and DJ Basins, driving a 40% increase in liquids volumes and a 32% increase in Rockies Segment Adjusted EBITDA. Combined with continued growth in our Permian and Mid-Con Segments, total Adjusted EBITDA reached $70.7 million, up 16% from the prior quarter. Since the first quarter, new well connects, volume growth and favorable commodity prices have added roughly $16.5 million of quarterly Adjusted EBITDA, approximately 30% growth in just two quarters. That momentum gives us the confidence to raise our full-year 2026 Adjusted EBITDA guidance range to $250 million to $260 million.

“On the commercial front, we reached a positive final investment decision on the Double E Mainline Compression Expansion, and volumes were at record levels during the quarter. Both reflect the growing reliance on Double E to meet in-basin gas transportation needs in the Permian. We continue to make great progress securing additional firm transportation contracts and remain on track to subscribe the remaining expansion capacity to Waha by year-end.

“Looking ahead, we are beginning to see a real step-change in the Company’s organic growth outlook over the next two to three years, driven primarily by our Rockies and Permian Segments. With seven rigs running behind our systems and approximately 140 DUCs, we currently expect to connect 200 to 250 wells in 2027, which will drive meaningful year-over-year volume and EBITDA growth. Our Rockies producers are also signaling plans to continue to grow activity levels and volumes well into 2028 and beyond. In the Permian, we’re seeing demand for in-basin gas transportation services on Double E not only filling up the Mainline Compression Expansion capacity to Waha but also utilizing the bidirectional capability of the system to access additional markets and outlets on the northern end of the pipeline. The combination of the strong growth outlook in the Rockies and Permian Segments, along with a steady outlook in the Mid-Con, could drive a mid-to-high-teens compound annual growth rate in Adjusted EBITDA over the next several years. We’re really excited about the momentum we’re seeing in the business and the progress we’ve made on the balance sheet, and we look forward to providing more specific financial guidance for 2027 early next year.”

Third Quarter 2026 Business Highlights

SMC’s average daily natural gas throughput on its wholly owned, operated systems increased 5.9% to 952 MMcf/d, while liquids volumes increased 39.7% to 95 Mbbl/d, relative to the second quarter of 2026. Double E Pipeline averaged 1,002 MMcf/d and contributed $11.2 million in Adjusted EBITDA, net to SMC, for the third quarter of 2026.

Natural gas price-driven segments:

  • Natural gas price-driven segments generated $31.1 million in combined Segment Adjusted EBITDA, a $1.0 million increase relative to the second quarter of 2026, with combined capital expenditures of $5.3 million
  • Mid-Con Segment Adjusted EBITDA totaled $22.8 million, an increase of approximately $1.4 million relative to the second quarter of 2026, primarily due to a 7.3% increase in natural gas volume throughput to 561 MMcf/d, reflecting a full quarter of contribution from wells connected in the second quarter across both the Barnett and Arkoma systems. There is currently one rig running in the Barnett.
  • Piceance Segment Adjusted EBITDA totaled $8.3 million, a decrease of $0.4 million relative to the second quarter of 2026, as higher operating expenses offset a 4.2% increase in volume throughput to 223 MMcf/d. There were no new wells connected to the system during the quarter.

Oil price-driven segments:

  • Oil price-driven segments generated $51.1 million in combined Segment Adjusted EBITDA, a $11.4 million increase relative to the second quarter of 2026, with combined capital expenditures of $15.0 million
  • Rockies Segment Adjusted EBITDA totaled $40.0 million, an increase of $9.6 million relative to the second quarter of 2026, driven by a 39.7% increase in liquids volume throughput. During the quarter, 51 new wells were connected to the Rockies systems, 32 in the Williston Basin and 19 in the DJ Basin, including 9 wells in the Williston for which Summit provides both crude oil and produced water gathering services, which meaningfully contributed to the uplift in liquids volumes. Third quarter results also include the benefit of approximately $3.7 million of commercial billing settlements. Six rigs are currently running in the Rockies Segment, including four in the Williston Basin and two in the DJ Basin, with approximately 140 DUCs behind the systems.
  • Permian Segment Adjusted EBITDA totaled $11.2 million, an increase of approximately $1.8 million relative to the second quarter of 2026, driven by new contracts placed into service during the quarter and a 16.6% increase in Double E volume throughput to 1,002 MMcf/d.

The following table presents average daily throughput by reportable segment for the periods indicated:

Three Months Ended
September 30,
Nine Months Ended
September 30,
2026202520262025
Average daily throughput (MMcf/d):
Rockies168158166145
Piceance223259221263
Mid-Con561508520500
Aggregate average daily throughput952925907908
Average daily throughput (Mbbl/d):
Rockies95727575
Aggregate average daily throughput95727575
Double E average daily throughput (MMcf/d) (1)1,002712890686
(1) Gross basis, represents 100% of volume throughput for Double E.

The following table presents adjusted EBITDA by reportable segment for the periods indicated:

Three Months Ended
September 30,
Nine Months Ended
September 30,
2026202520262025
(In thousands)
Reportable segment adjusted EBITDA (1):
Rockies39,96928,99996,70379,103
Permian (2)11,1538,67529,24725,245
Piceance8,30812,50926,54034,769
Mid-Con22,75223,55663,44070,913
Total$       82,182$       73,739$     215,930$     210,030
Less:  Corporate and Other (3)11,4928,24130,34925,932
Adjusted EBITDA (4)$       70,690$       65,498$     185,581$     184,098
(1)Segment adjusted EBITDA is a non-GAAP financial measure. We define segment adjusted EBITDA as total revenues less total costs and expenses, plus (i) other income (excluding interest income), (ii) our proportional adjusted EBITDA for equity method investees, (iii) depreciation and amortization, (iv) adjustments related to minimum volume commitments (“MVC”) shortfall payments, (v) adjustments related to capital reimbursement activity, (vi) share-based and noncash compensation, (vii) impairments and (viii) other noncash expenses or losses, less other noncash income or gains.
(2) Includes our proportional share of adjusted EBITDA for Double E. We define proportional adjusted EBITDA for our equity method investees as the product of total revenues less total expenses, excluding impairments and other noncash income or expense items; multiplied by our ownership interest during the respective period.
(3)Corporate and Other represents those results that are not specifically attributable to a reportable segment or that have not been allocated to our reportable segments, including certain general and administrative expense items and transaction costs.
(4)Adjusted EBITDA is a non-GAAP financial measure.

Capital Expenditures

Capital expenditures totaled $21.2 million in the third quarter of 2026, inclusive of maintenance capital expenditures of $4.7 million. Capital expenditures in the third quarter of 2026 were primarily related to pad connections in the Rockies and Mid-Con segments. SMC continues to expect full year 2026 capital expenditures, including Double E, of $100 million to $120 million, consistent with the guidance update provided with second quarter results, and currently expects to be near the high end of the range. The increase from SMC’s original 2026 guidance of $85 million to $105 million reflects incremental, high-return growth projects added during the year, including 30 additional Williston wells added to the program or accelerated from 2027 in response to customer activity, and incremental capital at Double E tied to new firm transportation agreements executed this year. These projects are underpinned by customer development plans and are expected to contribute to volume and Adjusted EBITDA growth in 2027.

Nine Months Ended
September 30,
20262025
(In thousands)
Cash paid for capital expenditures (1):
Rockies$         43,003$         30,696
Piceance1,6081,531
Mid-Con18,55935,210
Total reportable segment capital expenditures$         63,170$         67,437
Corporate and Other2,2942,473
Total cash paid for capital expenditures$         65,464$         69,910
(1) Excludes cash paid for capital expenditures by Double E due to equity method accounting.

Capital & Liquidity

As of September 30, 2026, SMC had $12.5 million in unrestricted cash-on-hand and $80 million drawn under its $500 million ABL Revolver with $417 million of borrowing availability, after accounting for $2.7 million of issued, but undrawn letters of credit. As of September 30, 2026, SMC was in compliance with all financial covenants, including interest coverage of 3.0x relative to a minimum interest coverage covenant of 2.0x and first lien net leverage ratio of 0.3x relative to a maximum first lien net leverage ratio of 2.5x. As of September 30, 2026, SMC reported a total net leverage ratio of approximately 3.9x.

As defined in the ABL credit agreement, the total net leverage ratio is calculated as the consolidated debt of Summit Midstream Holdings, LLC and its restricted subsidiaries, net of up to $50 million of unrestricted cash, divided by trailing twelve-month EBITDA as defined in the agreement. Summit Permian Transmission Holdco, LLC and Summit Permian Transmission, LLC are unrestricted subsidiaries under the agreement. Accordingly, the Permian Transmission Term Loan is excluded from debt, and credit agreement EBITDA excludes SMC’s proportional share of Double E’s Adjusted EBITDA and instead includes, subject to certain limitations, cash distributions received from Double E. Credit agreement EBITDA may also include adjustments for material capital projects and other items permitted under the agreement.

As of September 30, 2026, the Summit Permian Transmission Term Loan Facility had a balance of $360 million. Summit Midstream Permian has $9.2 million of cash-on-hand as of September 30, 2026. The Permian Transmission Term Loan remains non-recourse to SMC.

MVC Shortfall Payments

SMC billed its customers $4.1 million in the third quarter of 2026 related to MVC shortfalls. For those customers that do not have MVC shortfall credit banking mechanisms in their gathering agreements, the MVC shortfall payments are accounted for as gathering revenue in the period in which they are earned. In the third quarter of 2026, SMC recognized $4.1 million of gathering revenue associated with MVC shortfall payments. SMC had $0.0 million of adjustments to MVC shortfall payments in the third quarter of 2026. SMC’s MVC shortfall payment mechanisms contributed $4.1 million of total Adjusted EBITDA in the third quarter of 2026. The minimum volume commitments underpinning SMC’s Piceance segment gathering agreements, which represent substantially all of SMC’s MVC shortfall payments, expired at the end of the third quarter of 2026.

Quarterly Dividend

The Board of Directors of Summit Midstream Corporation continued to suspend cash dividends payable on the common stock for the period ended September 30, 2026. The quarterly cash dividend on the Series A Preferred Stock, for the period ending December 14, 2026, will be paid to preferred shareholders of record as of the close of business on December 1, 2026.

Share Repurchase Program

During the third quarter of 2026, SMC repurchased 7,007 shares of its common stock for approximately $0.2 million. As of September 30, 2026, SMC had approximately $33.8 million of remaining capacity under its $35.0 million share repurchase program.

Third Quarter 2026 Earnings Call Information

SMC will host a conference call at 10:00 a.m. Eastern on November 10, 2026, to discuss its quarterly operating and financial results. The call can be accessed via teleconference at:  Q3 2026 Summit Midstream Corporation Earnings Conference Call (https://register-conf.media-server.com/register/BI10be65af5cb84a17b15c9a100f09cd74). Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. The conference call, live webcast and archive of the call can be accessed through the Investors section of SMC’s website at www.summitmidstream.com.

Upcoming Investor Conferences

Members of SMC’s senior management team will attend the 2026 Bank of America Leveraged Finance Conference taking place on December 1–2, 2026 and the 2026 Wells Fargo Energy & Power Symposium taking place on December 8–9, 2026. The presentation materials associated with these events will be accessible through the Investors section of SMC’s website at www.summitmidstream.com prior to the beginning of each conference.

Use of Non-GAAP Financial Measures

We report financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). We also present adjusted EBITDA, segment adjusted EBITDA, Distributable Cash Flow, and Free Cash Flow, non-GAAP financial measures.

Adjusted EBITDA

We define adjusted EBITDA as net income or loss, plus interest expense, income tax expense, depreciation and amortization, our proportional adjusted EBITDA for equity method investees, adjustments related to MVC shortfall payments, adjustments related to capital reimbursement activity, share-based and noncash compensation, impairments, items of income or loss that we characterize as unrepresentative of our ongoing operations and other noncash expenses or losses, income tax benefit, income (loss) from equity method investees and other noncash income or gains. Because adjusted EBITDA may be defined differently by other entities in our industry, our definition of this non-GAAP financial measure may not be comparable to similarly titled measures of other entities, thereby diminishing its utility.

Management uses adjusted EBITDA in making financial, operating and planning decisions and in evaluating our financial performance. Furthermore, management believes that adjusted EBITDA may provide external users of our financial statements, such as investors, commercial banks, research analysts and others, with additional meaningful comparisons between current results and results of prior periods as they are expected to be reflective of our core ongoing business.

Adjusted EBITDA is used as a supplemental financial measure to assess:

  • the ability of our assets to generate cash sufficient to make future potential cash dividends and support our indebtedness;
  • the financial performance of our assets without regard to financing methods, capital structure or historical cost basis;
  • our operating performance and return on capital as compared to those of other entities in the midstream energy sector, without regard to financing or capital structure;
  • the attractiveness of capital projects and acquisitions and the overall rates of return on alternative investment opportunities; and
  • the financial performance of our assets without regard to (i) the impact of the timing of MVC shortfall payments under our gathering agreements or (ii) the timing of impairments or other income or expense items that we characterize as unrepresentative of our ongoing operations.

Adjusted EBITDA has limitations as an analytical tool and investors should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. For example:

  • adjusted EBITDA includes the Company’s proportionate share of Adjusted EBITDA from its unconsolidated equity method investee. Because this entity is not consolidated, the Company does not control its operations and does not have legal claim to its revenues, expenses, assets, liabilities, or cash flows, other than distributions received. As a result, this adjustment has limitations as an analytical measure and may not be comparable to similarly titled measures presented by other companies;
  • certain items excluded from adjusted EBITDA are significant components in understanding and assessing an entity’s financial performance, such as an entity’s cost of capital and tax structure;
  • adjusted EBITDA does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments;
  • adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; and
  • although depreciation and amortization are noncash charges, the assets being depreciated and amortized will often have to be replaced in the future, and adjusted EBITDA does not reflect any cash requirements for such replacements.

We compensate for the limitations of adjusted EBITDA as an analytical tool by reviewing the comparable GAAP financial measures, understanding the differences between the financial measures and incorporating these data points into our decision-making process.

Distributable Cash Flow

We define Distributable Cash Flow as adjusted EBITDA, as defined above, less cash interest paid, cash paid for taxes, net interest expense accrued and paid on the senior notes, and maintenance capital expenditures.

Free Cash Flow

We define free cash flow as distributable cash flow attributable to common and preferred shareholders less growth capital expenditures, less investments in equity method investees, less dividends to common and preferred shareholders. Free cash flow excludes proceeds from asset sales and cash consideration paid for acquisitions. 

We do not provide the GAAP financial measures of net income or loss or net cash provided by operating activities on a forward-looking basis because we are unable to predict, without unreasonable effort, certain components thereof including, but not limited to, (i) income or loss from equity method investees and (ii) asset impairments. These items are inherently uncertain and depend on various factors, many of which are beyond our control. As such, any associated estimate and its impact on our GAAP performance and cash flow measures could vary materially based on a variety of acceptable management assumptions.

About Summit Midstream Corporation

SMC is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets that are strategically located in the core producing areas of unconventional resource basins, primarily shale formations, in the continental United States. SMC provides natural gas, crude oil and produced water gathering, processing and transportation services pursuant to primarily long-term, fee-based agreements with customers and counterparties in five unconventional resource basins: (i) the Williston Basin, which includes the Bakken and Three Forks shale formations in North Dakota; (ii) the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; (iii) the Fort Worth Basin, which includes the Barnett Shale formation in Texas; (iv) the Arkoma Basin, which includes the Woodford and Caney shale formations in Oklahoma; and (v) the Piceance Basin, which includes the Mesaverde formation as well as the Mancos and Niobrara shale formations in Colorado. SMC has an equity method investment in Double E Pipeline, LLC, which provides interstate natural gas transportation service from multiple receipt points in the Delaware Basin to various delivery points in and around the Waha Hub in Texas. SMC is headquartered in Houston, Texas.

Forward-Looking Statements

This press release includes certain statements concerning expectations for the future that are forward-looking within the meaning of the federal securities laws. Forward-looking statements include, without limitation, any statement that may project, indicate or imply future results, events, performance or achievements and may contain the words “expect,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “will be,” “will continue,” “will likely result,” and similar expressions, or future conditional verbs such as “may,” “will,” “should,” “would” and “could.” In addition, any statement concerning future financial performance (including future revenues, earnings or growth rates), payment of dividends on any series of stock, ongoing business strategies and possible actions taken by SMC or its subsidiaries are also forward-looking statements. Forward-looking statements also contain known and unknown risks and uncertainties (many of which are difficult to predict and beyond management’s control) that may cause SMC’s actual results in future periods to differ materially from anticipated or projected results. An extensive list of specific material risks and uncertainties affecting SMC is contained in its 2025 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 16, 2026, as amended and updated from time to time. Any forward-looking statements in this press release are made as of the date of this press release and SMC undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

View full release here.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/summit-midstream-corporation-reports-third-quarter-2026-financial-and-operating-results-302933805.html

SOURCE Summit Midstream Corporation

832-413-4770, [email protected]

Release – SKYX Announces Third Quarter 2026 Earnings Conference Call and Corporate Update to Be Held Thursday, November 12, 2026, at 4:30 p.m. Eastern Time

logo

Research News and Market Data on SKYX

Company to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results

November 09, 2026 16:48 ET  | Source: SKYX Platforms Corp.

MIAMI, Nov. 09, 2026 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), an award-winning, highly disruptive advanced smart home and AI platform technology company with over 120 U.S. and global pending and issued patents and a portfolio of 60 lighting and home décor websites, with a mission to make homes and buildings advanced, safe and smart as the new standard, today announced that it will host its third quarter 2026 earnings conference call on Thursday, November 12, 2026, at 4:30 p.m. Eastern Time.

Management will provide a corporate update and discuss the Company’s third quarter 2026 financial results and recent business developments.

Participating Management

SKYX participating management members will include:

  • Rani Kohen, Founder and Executive Chairman
  • Lenny Sokolow, CEO
  • Steve Schmidt, SKYX President
  • Derek Richardson, CEO of Deako, SKYX’s Home and Builder Division
  • Marc Boisseau, CFO

Conference Call and Webcast Details

Event: SKYX Platforms Corp. Third Quarter 2026 Earnings Conference Call

Date: Thursday, November 12, 2026

Time: 4:30 p.m. Eastern Time

Participant Dial-In:

  • U.S./Canada (Toll-Free): 1-877-407-0792
  • International: 1-201-689-8263

Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1782763&tp_key=c59bf1a1a2

Call me™: https://callme.viavid.com/viavid/?callme=true&passcode=13760591&h=true&info=company&r=true&B=6

Participants may use the dial-in numbers above and be assisted by an operator or use the Call me™ link for instant telephone access. The Call me™ link will become active 15 minutes before the scheduled start time.

Please connect at least 10 minutes before the start of the call to ensure timely participation.

Telephone Replay

A telephone replay is expected to be available approximately three hours after the conference call and will remain available through Saturday, December 12, 2026, at 11:59 p.m. Eastern Time.

Replay Dial-In:

  • U.S./Canada (Toll-Free): 1-844-512-2921
  • International: 1-412-317-6671

Access ID: 13763842

About SKYX Platforms Corp.

SKYX Platforms Corp. (NASDAQ: SKYX) is an advanced smart home, artificial intelligence (AI), and plug-and-play technology platform company with a mission to make homes and buildings safe, advanced, and smart as the new standard. Following its merger with Deako, Inc., SKYX combines complementary technologies designed to simplify the installation, integration, and upgrading of smart home and building systems across residential, commercial, builder, and hospitality markets.

The combined company offers a broad portfolio of plug-and-play platform technologies and products spanning ceiling and wall electrical infrastructure, intelligent lighting and switches, smart home and AI-enabled solutions, and other connected home and building applications. By bringing together SKYX’s ceiling-based technologies and Deako’s established wall-switch platform, the company enables a more comprehensive approach to smart homes and buildings, reducing the complexity associated with traditional wired installations while enhancing convenience, safety, and functionality.

SKYX has a combined portfolio of more than 120 issued and pending U.S. and international patents and patent applications relating to smart home and building platforms, AI, and plug-and-play technologies. Including its wholly owned subsidiary, Deako, SKYX supplies plug-and-play smart lighting technologies to more than 60 U.S. homebuilders and builders. The merger expands SKYX’s opportunities across the homebuilder, professional, commercial, and hospitality markets, while creating potential for future recurring revenue through product upgrades and interchangeability, AI-enabled services, monitoring, subscriptions, and licensing.

In addition to its technology platforms, SKYX owns a portfolio of 60 lighting and home décor websites serving retail and commercial customers. Through its combined technologies and product portfolio, SKYX is focused on advancing the adoption of smart, connected, and safer environments in homes and buildings across the United States and internationally.

For more information, please visit www.skyx.com and www.deako.com.

Forward-Looking Statements

Certain statements made in this press release are not based on historical facts, but are forward-looking statements. These statements can be identified by the use of forward-looking terminology such as “aim,” “anticipate,” “believe,” “can,” “could,” “continue,” “estimate,” “expect,” “evaluate,” “forecast,” “guidance,” “intend,” “likely,” “may,” “might,” “objective,” “ongoing,” “outlook,” “plan,” “potential,” “predict,” “probable,” “project,” “seek,” “should,” “target” “view,” “will,” or “would,” or the negative thereof or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. These statements reflect the Company’s reasonable judgment with respect to future events and are subject to risks, uncertainties and other factors, many of which have outcomes difficult to predict and may be outside our control, that could cause actual results or outcomes to differ materially from those in the forward-looking statements. Such risks and uncertainties include statements relating to the Company’s ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its products and technologies and integrate its products and technologies with third-party platforms or technologies; the Company’s ability to achieve positive cash flows; the Company’s efforts and ability to drive the adoption of its products and technologies as a standard feature, including their use in homes, hotels, offices and cruise ships; the Company’s ability to capture market share; the Company’s estimates of its potential addressable market and demand for its products and technologies; the Company’s ability to raise additional capital to support its operations as needed, which may not be available on acceptable terms or at all; the Company’s ability to continue as a going concern; the Company’s ability to execute on any sales and licensing or other strategic opportunities; the possibility that any of the Company’s products will become National Electrical Code (NEC)-code or otherwise code mandatory in any jurisdiction, or that any of the Company’s current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all; risks arising from mergers, acquisitions, joint ventures and other collaborations; the Company’s ability to attract and retain key executives and qualified personnel; guidance provided by management, which may differ from the Company’s actual operating results; the potential impact of unstable market and economic conditions on the Company’s business, financial condition, and stock price; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its periodic reports on Form 10-K and Form 10-Q. There can be no assurance as to any of the foregoing matters. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by U.S. federal securities laws. 

Investor Relations Contacts:

Jeff Ramson
PCG Advisory
[email protected]

Ronald A. Both
Encore Investor Relations
[email protected]

Release – Sky Harbour Announces Two New Hangar Campus Developments at Van Nuys Airport (VNY) in Los Angeles

Sky Harbour Logo

Research News and Market Data on SKYH

Nov 9, 2026 7:00 AM Eastern Standard Time

WEST HARRISON, N.Y.–(BUSINESS WIRE)–Sky Harbour Group Corporation (NYSE: SKYH, SKYH WS) (“SHG” or the “Company”), an aviation infrastructure company building the first nationwide network of Home Base Operator (HBO) campuses for business aircraft, announced that the Los Angeles City Council has approved two ground leases at Van Nuys Airport (VNY) for the development of Sky Harbour HBO campuses. The ground leases are expected to be formally executed in the coming weeks. Van Nuys Airport is one of the most active general aviation airports in the country and is the primary business aviation gateway to Los Angeles.

“Van Nuys operators have actively been seeking the Sky Harbour Home Base Operator model, and we are excited to deliver it,” said Tal Keinan, CEO of Sky Harbour. “We are grateful to the Los Angeles City Council, the Board of Airport Commissioners, and to the Van Nuys and Los Angeles World Airports teams for their partnership. Sky Harbour plans to bring new and lasting value to the airport, to Los Angeles Business Aviation, and to the San Fernando Valley community.”

The VNY developments are expected to bring significant private investment to Van Nuys Airport and to create or sustain hundreds of local construction and operations jobs.

About Sky Harbour

Sky Harbour Group Corporation is an aviation infrastructure company developing the first nationwide network of Home-Basing campuses for business aircraft. The company develops, leases, and manages general aviation hangar campuses across the United States. Sky Harbour’s Home-Basing offering aims to provide private and corporate residents with the best physical infrastructure in business aviation, coupled with dedicated service, tailored specifically to based aircraft, offering the shortest time to wheels-up in business aviation. To learn more, visit www.skyharbour.group.

Forward Looking Statements

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements about the financial condition, results of operations, earnings outlook and prospects of SHG, including statements regarding our expectations for future results, our expectations for future ground leases, our plans for future capital raising activity, our expectations on future construction and development activities and lease renewals, and our plans for future financings. When used in this press release, the words “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict,” “should,” “would” and other similar words and expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements are based on the current expectations of the management of Sky Harbour Group Corporation (the “Company”) as applicable and are inherently subject to uncertainties and changes in circumstances. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. For more information about risks facing the Company, see the Company’s annual report on Form 10-K for the year ended December 31, 2025 and other filings the Company makes with the SEC from time to time. The Company’s statements herein speak only as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contacts

Sky Harbour Investor Relations: [email protected]
Attn: Francisco X. Gonzalez

Alliance Entertainment Leads ArtPics Funding Round with Strategic Investment

Primary Logo

Research News and Market Data on AENT

Investment expands Alliance’s participation in original Fine Art collectibles and builds on ArtPics’s existing use of Endstate Authentic’s NFC authentication technology

PLANTATION, Fla., Nov. 09, 2026 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (NASDAQ: AENT), a scaled entertainment commerce and collectibles platform serving content owners, brands, retailers and fans across music, movies, gaming, licensed merchandise and collectibles, with proprietary brands, authentication technology and reach across more than 35,000 retail and e-commerce storefronts, today announced a $500,000 strategic investment in ArtPics Inc. as the lead investor in the company’s current funding round. The investment, made through a Simple Agreement for Future Equity (SAFE), builds on Alliance’s existing commercial relationship with ArtPics and expands its participation in the market for original Fine Art collectibles.

Founded by collectibles entrepreneur and artist Gareb Shamus, ArtPics brings original Fine Art to the trading-card format. Each card is a unique work created directly by an artist, rather than a print or reproduction, combining the appeal of original art ownership with the accessibility and collectibility of trading cards. ArtPics already incorporates Endstate Authentic’s NFC technology into its original Fine Art trading cards, connecting physical artwork with digital authentication and ownership-related information.

ArtPics Fine Art Trading Cards

ArtPics recently extended its commercial relationship with Endstate Authentic for an additional two years, reinforcing the companies’ ongoing collaboration in NFC-enabled authentication. Alliance also sees opportunities to support ArtPics’ expansion through its established retail relationships, distribution infrastructure and direct-to-consumer fulfillment capabilities.

“ArtPics brings together two passionate collecting communities: Fine Art and trading cards,” said Jeff Walker, Chief Executive Officer of Alliance Entertainment. “Gareb has a strong understanding of collectors and how to build a business around what they love. What makes this particularly compelling for us is that ArtPics is already using Endstate Authentic’s technology to authenticate these one-of-a-kind works. We are excited to lead this funding round and see opportunities to help ArtPics reach more collectors through Alliance’s relationships and capabilities.”

“We’re incredibly excited for Alliance Entertainment to lead ArtPics’ new funding round,” said Gareb Shamus, Founder and CEO of ArtPics. “We’ve worked closely with Endstate over the past year, integrating their patented NFC technology to help authenticate and protect every original ArtPics Fine Art trading card. As collecting and secondary markets continue to grow worldwide, this technology will play an integral role in the future of collectibles. Together with Alliance and Endstate Authentic, we’re combining original art, the excitement of trading cards, and physical ownership supported by digital authentication and provenance records to create an entirely new collecting experience for fans around the world.”

The strategic investment comes amid continued interest in original art and distinctive collectibles. According to the Art Basel and UBS Global Art Market Report 2026, global art sales increased 4% to an estimated $59.6 billion in 2025. A separate 2026 Art Basel and UBS survey found that 43% of surveyed high-net-worth collectors identified uniqueness and rarity as the most important attributes of art ownership. ArtPics’ one-of-one format brings those characteristics to a product designed to appeal to both art collectors and trading-card enthusiasts.

About ArtPics

ArtPics brings original Fine Art to the trading-card format, creating a new way for collectors to discover, own and trade one-of-a-kind artwork. Each card features an original work created by an artist, rather than a print or reproduction, and is encapsulated and equipped with NFC-enabled technology that connects the physical artwork to digital authentication and provenance records. Founded by Gareb and Stephen Shamus, ArtPics works with a growing roster of artists to make original fine art more accessible to collectors. Gareb Shamus is the founder of Wizard Entertainment and co-founder of ACE Comic Con, and previously published iconic entertainment and collectibles magazines including Wizard, ToyFare, InQuest Gamer, and Anime Insider.

Learn more at artpicscards.com and on Instagram at @artpicscards.

About Alliance Entertainment

Alliance Entertainment (NASDAQ: AENT) is a premier distributor and fulfillment partner for the entertainment and pop culture collectibles industry. With more than 340,000 unique in-stock SKUs – including over 57,300 exclusive titles across compact discs, vinyl LPs, DVDs, Blu-rays, and video games – Alliance offers the largest selection of physical media in the market. Our vast catalog also includes licensed merchandise, toys, retro gaming products, and collectibles, serving over 35,000 retail locations and powering e-commerce fulfillment for leading retailers. Alliance also owns and operates proprietary collectibles brands, including Handmade by Robots™, a stylized vinyl figure line featuring licensed characters from leading entertainment franchises, and Alliance Authentic™, a premium platform for authentic, certified, and individually numbered entertainment collectibles. In addition, Alliance operates Endstate Authentic, a dedicated NFC-enabled authentication and digital product identity platform supporting authenticated collectibles, resale, and brand protection. Leveraging decades of operational expertise, exclusive sourcing relationships, and a capital-light, scalable infrastructure, Alliance connects fans and collectors to the products, franchises, and experiences they value across formats and generations. For more information, visit www.aent.com.

Forward Looking Statements

Certain statements included in this Press Release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity. These statements are based on various assumptions, whether identified in this Press Release, and on the current expectations of Alliance’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Alliance. These forward-looking statements are subject to a number of risks and uncertainties, including risks relating to the anticipated growth rates and market opportunities; changes in applicable laws or regulations; the ability of Alliance to execute its business model, including market acceptance of its systems and related services; Alliance’s reliance on a concentration of suppliers for its products and services; increases in Alliance’s costs, disruption of supply, or shortage of products and materials; Alliance’s dependence on a concentration of customers, and failure to add new customers or expand sales to Alliance’s existing customers; increased Alliance inventory and risk of obsolescence; Alliance’s significant amount of indebtedness; our ability to refinance our existing indebtedness; risks that a breach of the revolving credit facility could result in the lender declaring a default and that the full outstanding amount under the revolving credit facility could be immediately due in full, which would have severe adverse consequences for the Company; known or future litigation and regulatory enforcement risks, including the diversion of time and attention and the additional costs and demands on Alliance’s resources; Alliance’s business being adversely affected by increased inflation, uncertainty regarding tariffs, higher interest rates and other adverse economic, business, and/or competitive factors; geopolitical risk and changes in applicable laws or regulations; as well as our financial condition and results of operations; substantial regulations, which are evolving, and unfavorable changes or failure by Alliance to comply with these regulations; product liability claims, which could harm Alliance’s financial condition and liquidity if Alliance is not able to successfully defend or insure against such claims; availability of additional capital to support business growth; and the inability of Alliance to develop and maintain effective internal controls.

Alliance Investor Contact

Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
[email protected]

ArtPics Investor and Media Contact

Gareb Shamus
Founder and CEO, ArtPics
[email protected]
artpicscards.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c3cef7ef-2f93-4217-979f-4d5b363477e0

Release – Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment

Tectonic Metals Logo

Research News and Market Data on TETOF

Download the PDF

Two strategic executive appointments bring proven experience in advancing a major gold mine into production, environmental permitting and Alaska Native partnerships as Tectonic prepares for key milestones at its Flat Gold Project

VANCOUVER, B.C., November 9, 2026 – Tectonic Metals Inc. (“Tectonic” or the “Company”)
(TSX-V: TECT; OTCQX: TETOF) is pleased to announce the appointments of Mr. Mark Warbanski as Vice President, Project Development, Environment & Permitting and Ms. Janine Bedford as Vice President, External Relations, effective October 23, 2026, and November 9, 2026, respectively.

The appointments mark an important step in Tectonic’s evolution as the Company prepares to deliver a maiden Mineral Resource Estimate for Chicken Mountain targeted for the first quarter of 2027, followed by a Preliminary Economic Assessment (“PEA”) targeted in the second quarter of 2027.

Together, Mr. Warbanski and Ms. Bedford bring more than four decades of experience spanning mine development, construction, environmental management, regulatory approvals, Alaska Native and Indigenous partnerships, government relations and community engagement. Their complementary mandates are designed to integrate disciplined project planning with environmental stewardship and meaningful engagement as Flat advances through economic studies and future development.

Tony Reda, Co-Founder, President and CEO, commented:

“Tectonic is entering a stage where exploration success must be supported by disciplined project planning and strong external relations. Mark and Janine bring both.

“Mark brings a rare combination of project development experience, from environmental assessment through construction, operational readiness and production, much of it at remote, cold-climate sites like ours. His hands-on experience, technical depth and focus on cost and schedule discipline will be invaluable as we advance Flat through economic studies and begin laying the groundwork for potential future development.

“Janine has spent her career earning the trust of the communities around mining projects, including in Alaska. Her experience working under major agreements with Alaska Native corporations is directly relevant to our partnership with Doyon, Limited and our long-term plans at Flat. Her approach to genuine collaboration will be invaluable as we build on that foundation with our partners to help ensure Flat advances responsibly, in step with the people closest to it.

“As a co-founder of Tectonic, nothing makes me prouder than the people who have chosen to build the Company together. Mark and Janine share our People First philosophy, our commitment to excellence and our belief that how we achieve success matters just as much as what we achieve. We are thrilled to welcome them to the team.”

Mark Warbanski – Vice President, Project Development, Environment & Permitting

Mr. Warbanski brings more than 20 years of natural resource experience, most recently helping advance Artemis Gold’s Blackwater Mine in central British Columbia from early construction through commissioning and into commercial production. As Manager, Environment, he built and led a large team of staff, contractors and consultants, established environmental management and regulatory compliance systems, and played a key role in integrating engineering, permitting, water management and environmental requirements into construction and commercial operations. His leadership also contributed to significant cost efficiencies, major habitat offsetting initiatives and effective collaboration with regulators and Indigenous partners.

Previously, Mr. Warbanski held environmental and project execution roles at Gitxaala Environmental, Newcrest Mining’s Red Chris Mine, Seabridge Gold’s KSM Project and Cameco’s Cigar Lake and McArthur River operations. His experience includes remote-site infrastructure development, including access roads, bridges and camps, as well as contributions to the environmental assessment and permitting of the Red Chris Block Cave project.

At Tectonic, he will lead the integration of technical studies, engineering, permitting and infrastructure planning as Flat advances through its PEA and subsequent stages of project evaluation, with an emphasis on practical execution, cost discipline and responsible development. He holds a B.Sc. in Toxicology from the University of Saskatchewan and is an ISO 14001 Lead Auditor.

Janine Bedford – Vice President, External Relations

Ms. Bedford brings more than 20 years of experience building Indigenous partnerships, strengthening community relationships and leading external relations across mining and energy projects in North America.

She spent five years at Teck Resources’ Red Dog Mine in Alaska, where she led the community and public relations team. As part of the long-standing Teck-NANA partnership, she collaborated closely with NANA Regional Corporation, regional leadership and 11 Iñupiat communities. Her responsibilities included community engagement, developing a social performance management system, integrating community perspectives into mine planning and operations, and supporting implementation and governance arrangements for the Northwest Arctic Borough’s Village Improvement Fund, a community-driven regional investment program.

At Newcrest Mining, Ms. Bedford established and led the Canadian social performance and communications function, building a team of nearly 20 people to support operating mines and exploration projects. She developed a comprehensive social performance management system and integrated human rights due diligence to support operational readiness. At Red Chris in northwestern British Columbia, she worked on the integration of the Tahltan Nation’s Impact Benefit and Co-Management Agreement, helping ensure its commitments were reflected in operational planning and decision-making.

Most recently, as Manager, North America, Communities & Social Performance at Fortescue, she helped advance the company’s relationship with the Tłı̨chǫ Government of the Northwest Territories, contributing to a formal minerals cooperation framework focused on exploration and capacity building. She also led external relations across a multi-jurisdictional portfolio of mineral exploration and green energy projects in Canada and the United States.

At Tectonic, Ms. Bedford will lead Alaska Native, community and government relations, working closely with Doyon, Limited and regional communities to strengthen relationships, coordinate engagement and ensure community perspectives inform the Company’s planning and activities as Flat advances.

She holds a Master of Research from the University of St Andrews and a joint B.A. in Sociology and Anthropology from Simon Fraser University, and is an alumna of the Ch’nook Indigenous Management Program at the UBC Sauder School of Business.

About Tectonic Metals Inc.

Tectonic Metals Inc. is a mineral exploration company led by an experienced and well-respected technical and financial team with a track record of wealth creation for shareholders. The Company is focused on exploring and developing its flagship Flat Gold Project in southwestern Alaska, covering 99,840 acres of predominantly Native-owned land belonging to Doyon, Limited, a leading Alaska Native Regional Corporation and one of Tectonic’s largest shareholders. The current focus is on advancing the Chicken Mountain target, one of six multi-kilometre-scale intrusion zones at the Flat Gold Project, where drilling has achieved a 100% success rate across 206 holes to date.

Founded by key members of the Kaminak Gold team behind the discovery and advancement of the Coffee Gold Project, which was acquired by Goldcorp for $520 million in 2016, Tectonic brings a proven track record in exploration, project advancement, capital markets and value creation. Collectively, the team has helped identify 40 million ounces of gold, advanced more than 20 projects through to feasibility, permitted 25 projects, completed over $6 billion in mergers and acquisitions and raised more than $6 billion in capital.

Tectonic’s mission is to be a shift in the game: working for our shareholders and the communities where we operate, putting people first, playing big and staying true to our word every step of the way.

On behalf of Tectonic Metals Inc.,  

Tony Reda, President and Chief Executive Officer  

For further information about Tectonic Metals Inc. or this news release, please visit our website at www.tectonicmetals.com or contact:

Keren Yun
Vice President, Investor Relations
1-888-685-8558 or [email protected].

Cautionary Note Regarding Forward-Looking Statements, Historical Information and Visual Observations

This news release contains “forward-looking statements” and “forward-looking information” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities laws. All statements herein that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often, but not always, identified by words such as “may,” “will,” “should,” “anticipate,” “believe,” “expect,” “intend,” “plan,” “estimate,” “potential,” “target,” or similar terminology, or that events or conditions “may” or “will” occur.

Forward-looking statements in this release include, but are not limited to, statements regarding the potential for mineralization at Tectonic’s projects; the nature, scope, and timing of future exploration activities; the interpretation of geological observations; the possible size or scale of mineralized systems; the receipt of regulatory approvals, and the anticipated benefits of current and future exploration programs.

Forward-looking statements are not guarantees of future performance. They are based on a number of assumptions made as of the date such statements are provided, including, among others: assumptions regarding future gold and other metal prices; currency exchange and interest rates; favourable operating and political conditions; timely receipt of permits and regulatory approvals; availability of labour, equipment, and services; stability of financial and capital markets; availability of financing on acceptable terms; accuracy of exploration data and geological models; and the ability to successfully advance planned exploration programs. Many of these assumptions are beyond the control of Tectonic and may prove to be incorrect.

Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. These risks include, without limitation: risks inherent to mineral exploration and development; volatility of commodity prices; changes in laws, regulations, and policies; delays or inability to obtain required approvals and permits; availability of financing; general economic, political, and market conditions; labour disputes and shortages; equipment and supply risks; environmental and social risks; competition; inaccuracies in exploration results or geological interpretations; and other risks detailed from time to time in the Company’s continuous disclosure filings.

Although management believes the expectations expressed in such forward-looking statements are reasonable as of the date made, there can be no assurance they will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements, historical information, or preliminary visual geological observations. Actual results and future events may differ materially from those anticipated. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Tectonic disclaims any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Release – Kratos Awarded Contract to Deliver Fully Integrated Q/V/Ka-Band Gateway and Antenna Systems for Gulf Space Technology’s Software-Defined Satellite

Primary Logo

Research News and Market Data on KTOS

November 9, 2026

PDF VersionTurnkey high-capacity gateway infrastructure with integrated monitoring and control complements Kratos’ ongoing development of Gulf Space Technology’s Satellite Operations Center

SAN DIEGO, Nov. 09, 2026 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in defense, national security and global markets, announced today that Gulf Space Technology Public Company Limited (GST), formerly Thaicom, a leading satellite and space technology company in the Asian market, has awarded Kratos a contract to deliver the first Q/V/Ka-band gateway antenna systems for the THAICOM 10, a software-defined high throughput satellite (SD-HTS). This enhanced feeder‑link capacity is essential for Gulf Space Technology to monetize the flexibility of THAICOM 10 and accelerate time‑to‑market for new services.

This new gateway supports the strategic direction of Gulf Space Technology as the company transitions from a satellite operator to a broader space technology provider participating in the New Space Economy. The gateway infrastructure also integrates Kratos’ Monitoring & Control (M&C) System and builds on Kratos’ delivery of GST’s Satellite Operations Center (SOC), ensuring continuity across the company’s evolving space‑to‑ground operations.

Gulf Space Technology is modernizing its space and ground capabilities with the upcoming launch of THAICOM 10, its first fully software-defined satellite. The flexibility of THAICOM 10’s payload, capable of dynamically adjusting capacity, coverage and service configuration while in orbit, requires equally agile ground systems to ensure coordinated satellite and gateway operations.

Kratos’ next-generation Q/V/Ka-band gateway provides the feeder-link performance needed to fully exploit THAICOM 10’s adaptive payload. Operating in higher frequency bands enables higher throughput, an approximate two to three times increase in bandwidth compared to Ka-band HTS and more dynamic allocation of resources across beams and service regions. The multi-site gateway architecture also enhances service continuity by enabling seamless diversity switching to mitigate weather-related degradation in Q/V/Ka-band operations.

“As software-defined satellites continue to transform how operators deliver services, advanced gateway systems become essential for unlocking their full potential,” said John Chay, Vice President of the APAC region for Kratos. “This next-generation Q/V/Ka-band gateway infrastructure will work seamlessly with the Satellite Operations Center currently under development, giving Gulf Space Technology a unified space-to-ground architecture capable of dynamically responding to customer and market demands, supporting the company’s growth strategy.”

Under the award, Kratos will deliver Q/V/Ka-band antennas, RF equipment, fiber-optic transport systems, timing and reference subsystems, and full gateway site infrastructure across primary and planned diversity locations. The integrated M&C system will provide end-to-end monitoring and control across all gateway elements enabling real-time equipment status, advanced alarm correlation, automated control actions, diversity switching to mitigate weather fade and a seamless interface to Gulf Space Technology’s satellite operations center.

“By delivering a complete turnkey Q/V/Ka-band gateway, Kratos is providing Gulf Space Technology with critical infrastructure that supports both our operational needs and our broader transformation into a space technology company,” said Park Boonyubol, Head of Satellite Programs at Gulf Space Technology. “Kratos’ long-standing performance supporting Thaicom satellites such as THAICOM 8, along with their ongoing work on our THAICOM 10 Satellite Operations Center, strengthens our ability to fully maximize the flexibility, throughput and value of our software-defined satellite.”

Kratos has a proven history of delivering advanced ground segment capabilities to commercial and government satellite operators worldwide including previous projects with Thaicom. Its end-to-end software-defined satellite support capabilities span satellite Command and Control (C2), Telemetry, Tracking and Command (TT&C), payload and resource management, network orchestration, performance monitoring, spectrum management and critical gateway systems. The integrated delivery of the SOC and the new Q/V/Ka-band gateway system positions Gulf Space Technology with a unified operational environment to rapidly adapt to evolving customer requirements and market conditions.

About Kratos Defense & Security Solutions
Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) is a technology, products, system and software company addressing defense, national security, and commercial markets. Kratos makes true internally funded research, development, capital and other investments, to rapidly develop, produce and field solutions that address our customers’ mission critical needs and requirements. At Kratos, affordability is a technology, and we seek to utilize proven, leading-edge approaches and technology, not unproven bleeding edge approaches or technology, with Kratos’ approach designed to reduce cost, schedule and risk, enabling us to be first to market with cost effective solutions. We believe that Kratos is known as an innovative disruptive change agent in the industry, a company that is an expert in designing products and systems up front for successful rapid, large quantity, low-cost future manufacturing which is a value-add competitive differentiator for our large traditional prime system integrator partners and also to our government and commercial customers. Kratos intends to pursue program and contract opportunities as the prime or lead contractor when we believe that our probability of win (PWin) is high and any investment required by Kratos is within our capital resource comfort level. We intend to partner and team with a large, traditional system integrator when our assessment of PWin is greater or required investment is beyond Kratos’ comfort level. Kratos’ primary business areas include virtualized ground systems for satellites and space vehicles including software for command & control and telemetry, tracking and control, jet powered unmanned aerial drone systems, hypersonic vehicles and rocket systems, propulsion systems for drones, missiles, loitering munitions, supersonic systems, space craft and launch systems, C5ISR and microwave electronic products for missile, radar, missile defense, space, satellite, counter unmanned aircraft systems, directed energy, communication and other systems, and virtual & augmented reality training systems for the warfighter. For more information, visit www.KratosDefense.com and follow Kratos on LinkedIn and X.

About Gulf Space Technology
Gulf Space Technology Public Company Limited (SET: GST), formerly Thaicom Public Company Limited, is a leading Asian space technology and satellite communications provider. Building on extensive satellite communications experience and next-generation infrastructure, the company delivers integrated space-based data services, broadband connectivity, broadcasting, and geospatial intelligence solutions while expanding into critical digital infrastructure to meet evolving connectivity and data needs. Gulf Space Technology aims to unlock opportunities in the New Space Economy, strengthen Thailand’s ability to manage critical data through domestic infrastructure and service providers, support digital transformation, and foster secure, sustainable long-term economic growth across the region.

Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether because of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 28, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the Security and Exchange Commission by Kratos.

Press Contact:
Claire Cantrell
[email protected]

Investor Information:
877-934-4687
[email protected]

Primary Logo